Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
SUNNYVALE, California, June 19 /PRNewswire/ --
- Cytori and UC lose rights to Adipose-Derived Stem Cells; business agreements and activity under other patents likely affected.
Artecel, Inc., announced today that the patent inventorship litigation concerning the foundational, composition-of-matter patent covering stem cells isolated from adipose (fat) tissue has been decided in favor of Artecel's licensor, the University of Pittsburgh ('Pittsburgh') and against Cytori Therapeutics' licensor, the University of California ('UC'). Such stem cells are one of the most promising kinds of adult stem…